Betty Albo

Betty Albo practices at AdventHealth Ocala in Ocala, Florida.

Betty Albo's NPI, 1619409653, was assigned on March 29, 2017. Betty Albo graduated from Universidad Central del Caribe School of Medicine in 2017. Betty Albo holds Florida license ME145206.

Betty Albo's primary practice is AdventHealth Ocala, at 1500 Sw 1st Ave, Ocala, FL 34471. The practice phone is (352) 351-7282.

Betty Albo's primary practice is AdventHealth Ocala in Ocala, Florida. Betty Albo is also affiliated with AdventHealth Ocala. The medical group on file is AdventHealth Medical Group Cardiovascular Surgery at Tampa. Dmand AI also links Betty Albo to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Betty Albo practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Betty Albo's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Betty Albo is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Betty Albo's licenses on file in 2 states: Florida and Massachusetts.

CMS data shows 259 Medicare services from Betty Albo across 3 procedure codes in 2024, for 111 Medicare patients. Medicare paid $23,314 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Betty Albo in 2024. The largest group is 75 to 84, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Betty Albo's median patient age at 69, with 52% women.

In 2024, Betty Albo wrote 202 Medicare Part D claims for 101 patients. 90% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $99 in total drug cost.

Betty Albo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Betty Albo, published from 2020 to 2025. Betty Albo has published most often in Dig Dis Sci. Betty Albo's most frequent co-authors are Yasir H. Al-Azzawi, MD, Muhammad Alsayid, MD and Mohanad S. Awadalla, MD.

CMS Open Payments shows 7 general payments to Betty Albo from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $215.

Betty Albo graduated from Universidad Central del Caribe School of Medicine in 2017.

Betty Albo is in network with 2 carriers, including Aetna and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.